68-3

99/130

) Morimoto Y, Tohya M, Aibibula Z, Baba T, Daida H, Kirikae T: Re-identification of strains deposited as Pseudomonas aeruginosa, Pseu-domonas fluorescens and Pseudomonas putida in GenBank based on whole genome sequences. Int J Syst Evol Microbiol, 2020; 70: 5958-5963.) Iwata S, Tada T, Hishinuma T, Tohya M, Oshiro S, Kuwahara-Arai K, Ogawa M, Shimo-jima M, Kirikae T: Emergence of carbapen-em-resistant Providencia rettgeri and Provi-dencia stuartii producing IMP-type metallo- beta-lactamase in Japan. Antimicrob Agents Chemother, 2020; 64.) Singh M, Matsuo M, Sasaki T, Hishinuma T, Yamamoto N, Morimoto Y, Kirikae T, Hira-matsu K: RNA sequencing identifies a common physiology in vancomycin- and ciprofloxa-cin-tolerant Staphylococcus aureus induced by ileS mutations. Antimicrob Agents Chemo-ther, 2020; 64.) Lu Y.J, Morimoto Y, Tohya M, Hishinuma T, Hiramatsu K, Kirikae T, Baba T: Pseudo-monas izuensis sp. nov., a novel species isolated from Izu Oshima, Japan. Int J Syst Evol Microbiol, 2020; 70: 4212-4216.) Tohya M, Watanabe S, Teramoto K, Tada T, Kuwahara-Arai K, Mya S, Zin K.N, Kirikae T, Tin H.H: Pseudomonas yangonensis sp. nov., isolated from wound samples of patients in a hospital in Myanmar. Int J Syst Evol Microbiol, 2020; 70: 3597-3605.) Okabe T, Togo S, Fujimoto Y, Watanabe J, Sumiyoshi I, Orimo A, Takahashi K: Mesen-chymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy. Cancers, 2020; 12: 3588. doi: 10.3390/cancers12123588.) Yoshida G.J, Azuma A, Miura Y, Orimo A: (2020) Activated Fibroblast Program Orches-trates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies. In: Song Guo Zheng, editor. Prime Archives in Molecular Biology. Hyderabad, India: Vide Leaf. ) Ohno M.K, Kirikae T, Yoshihara E, Kirikae F, Ishida I: Addition of L-cysteine to the N- or C-terminus of the all-D-enantiomer [D(KLAKLAK)2] increases antimicrobial activities against multidrug-resistant Pseu-domonas aeruginosa, Acinetobacter baumannii and Escherichia coli. PeerJ, 2020; 8: e10176.) Tohya M, Uechi K, Tada T, Hishinuma T, Kinjo T, Ohshiro T, Maeda S, Kirikae T, Fujita J: Emergence of clinical isolates of Pseudomonas asiatica and Pseudomonas monteilii from Japan harbouring an acquired gene encoding a carbapenemase VIM-2. J Med Microbiol, 2020.) Tagashira Y, Takamatsu A, Hasegawa S, Uenoyama Y, Honda H: A survey of prepared-ness against coronavirus disease 2019 (COVID-19) in hospitals in Tokyo, Japan, with healthcare personnel with COVID-19 and in-facility transmission. Infect Control Hosp Epidemiol, 2020; 1-5.) Hishinuma T, Uchida H, Tohya M, Shimojima M, Tada T, Kirikae T: Emergence and spread of VIM-type metallo-beta-lactamase-pro-ducing Pseudomonas aeruginosa clinical isolates in Japan. J Glob Antimicrob Resist, 2020; 23: 265-268.coids in Severe ANCA-Associated Vasculitis. N Engl J Med, 2020; 13; 382: 622-631. doi: 10.1056/NEJMoa1803537. PMID: 32053298; PMCID: PMC7325726.〈Reviews〉 1〈Books〉 1Microbiology〈Original Articles〉 1 2 3 4 5 6 7 8 9＊ 10) Shibuya R, Uehara Y, Baba T, Teruya K, Satou K, Hirano T, Kirikae T, Hiramatsu K: Complete genome sequence of a methicillin- resistant Staphylococcus lugdunensis strain and characteristics of its staphylococcal cassette chromosome mec. Sci Rep, 2020; 10: 8682. 11) Tohya M, Watanabe S, Tada T, Tin H.H, Kirikae T: Genome analysis-based reclassifi-cation of Pseudomonas fuscovaginae and Pseudomonas shirazica as later heterotypic synonyms of Pseudomonas asplenii and Pseu-domonas asiatica, respectively. Int J Syst Evol Microbiol, 2020; 70: 3547-3552. 12) Kananizadeh P, Oshiro S, Watanabe S, Iwata S, Kuwahara-Arai K, Shimojima M, Ogawa M, Tada T, Kirikae T: Emergence of carbap-enem-resistant and colistin-susceptible Entero-295